BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 8906817)

  • 21. Natural killer T cells are required for the development of a superantigen-driven T helper type 2 immune response in mice.
    Nomizo A; Postol E; de Alencar R; Cardillo F; Mengel J
    Immunology; 2005 Oct; 116(2):233-44. PubMed ID: 16162272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MHC class II-dependent NK1.1+ gammadelta T cells are induced in mice by Salmonella infection.
    Nishimura H; Washizu J; Naiki Y; Hara T; Fukui Y; Sasazuki T; Yoshikai Y
    J Immunol; 1999 Feb; 162(3):1573-81. PubMed ID: 9973415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of NK1.1+ cells in experimental listeriosis. NK1+ cells are early IFN-gamma producers but impair resistance to Listeria monocytogenes infection.
    Teixeira HC; Kaufmann SH
    J Immunol; 1994 Feb; 152(4):1873-82. PubMed ID: 8120395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus.
    Zeng D; Gazit G; Dejbakhsh-Jones S; Balk SP; Snapper S; Taniguchi M; Strober S
    J Immunol; 1999 Nov; 163(10):5338-45. PubMed ID: 10553057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases.
    Palanivel V; Posey C; Horauf AM; Solbach W; Piessens WF; Harn DA
    Exp Parasitol; 1996 Nov; 84(2):168-77. PubMed ID: 8932766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NK1.1+ CD4+ T cells lose NK1.1 expression upon in vitro activation.
    Chen H; Huang H; Paul WE
    J Immunol; 1997 Jun; 158(11):5112-9. PubMed ID: 9164926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
    Mocci S; Coffman RL
    J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.
    Schulz RJ; Parkes A; Mizoguchi E; Bhan AK; Koyasu S
    J Immunol; 1996 Nov; 157(10):4379-89. PubMed ID: 8906813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predominant appearance of NK1.1+ T cells producing IL-4 may be involved in the increased susceptibility of mice with the beige mutation during Salmonella infection.
    Enomoto A; Nishimura H; Yoshikai Y
    J Immunol; 1997 Mar; 158(5):2268-77. PubMed ID: 9036974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells.
    Tomura M; Zhou XY; Maruo S; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Tanimoto T; Kurimoto M; Fujiwara H
    J Immunol; 1998 May; 160(10):4738-46. PubMed ID: 9590219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional plasticity of the LACK-reactive Vbeta4-Valpha8 CD4(+) T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB / c mice.
    Maillard I; Launois P; Himmelrich H; Acha-Orbea H; Diggelmann H; Locksley RM; Louis JA
    Eur J Immunol; 2001 Apr; 31(4):1288-96. PubMed ID: 11298356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of IL-4-producing Vbeta8.2+ CD4+ CD62L- CD45RB- T cells in non-MHC gene-controlled predisposition toward skewing into T helper type-2 immunity in BALB/c mice.
    Nishimura T; Santa K; Yahata T; Sato N; Ohta A; Ohmi Y; Sato T; Hozumi K; Habu S
    J Immunol; 1997 Jun; 158(12):5698-706. PubMed ID: 9190919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory role of peritoneal NK1.1+ alpha beta T cells in IL-12 production during Salmonella infection.
    Naiki Y; Nishimura H; Kawano T; Tanaka Y; Itohara S; Taniguchi M; Yoshikai Y
    J Immunol; 1999 Aug; 163(4):2057-63. PubMed ID: 10438944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of Leishmania major infection in BALB/c mice by inhibition of early lymphocyte entry into peripheral lymph nodes.
    Laskay T; Wittmann I; Diefenbach A; Röllinghoff M; Solbach W
    J Immunol; 1997 Feb; 158(3):1246-53. PubMed ID: 9013966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion.
    Arase H; Arase N; Nakagawa K; Good RA; Onoé K
    Eur J Immunol; 1993 Jan; 23(1):307-10. PubMed ID: 8419184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.